↓ Skip to main content

Detecting an Overall Survival Benefit that Is Derived From Progression-Free Survival

Overview of attention for article published in JNCI: Journal of the National Cancer Institute, November 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news
2 news outlets
policy
1 policy source
twitter
5 X users
facebook
1 Facebook page

Citations

dimensions_citation
418 Dimensions

Readers on

mendeley
176 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Detecting an Overall Survival Benefit that Is Derived From Progression-Free Survival
Published in
JNCI: Journal of the National Cancer Institute, November 2009
DOI 10.1093/jnci/djp369
Pubmed ID
Authors

Kristine R. Broglio, Donald A. Berry

Abstract

Whether progression-free survival (PFS) or overall survival (OS) is the more appropriate endpoint in clinical trials of metastatic cancer is controversial. In some disease and treatment settings, an improvement in PFS does not result in an improved OS.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 176 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 4 2%
United Kingdom 2 1%
Portugal 1 <1%
Belgium 1 <1%
Australia 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 165 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 42 24%
Other 21 12%
Student > Ph. D. Student 18 10%
Student > Master 12 7%
Student > Postgraduate 11 6%
Other 32 18%
Unknown 40 23%
Readers by discipline Count As %
Medicine and Dentistry 83 47%
Mathematics 13 7%
Biochemistry, Genetics and Molecular Biology 5 3%
Agricultural and Biological Sciences 4 2%
Economics, Econometrics and Finance 4 2%
Other 16 9%
Unknown 51 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2023.
All research outputs
#1,617,930
of 25,373,627 outputs
Outputs from JNCI: Journal of the National Cancer Institute
#1,043
of 7,844 outputs
Outputs of similar age
#4,820
of 108,085 outputs
Outputs of similar age from JNCI: Journal of the National Cancer Institute
#8
of 32 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,844 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 108,085 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.